EG23929A - Isoxazolines derivatives and their use as antidepressants - Google Patents
Isoxazolines derivatives and their use as antidepressantsInfo
- Publication number
- EG23929A EG23929A EG20020197A EG20020197A EG23929A EG 23929 A EG23929 A EG 23929A EG 20020197 A EG20020197 A EG 20020197A EG 20020197 A EG20020197 A EG 20020197A EG 23929 A EG23929 A EG 23929A
- Authority
- EG
- Egypt
- Prior art keywords
- antidepressants
- isoxazolines
- derivatives
- isoxazolines derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01200611 | 2001-02-21 | ||
| EP01201264 | 2001-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG23929A true EG23929A (en) | 2008-01-14 |
Family
ID=26076836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG20020197A EG23929A (en) | 2001-02-21 | 2002-02-19 | Isoxazolines derivatives and their use as antidepressants |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7169786B2 (et) |
| EP (1) | EP1368358B1 (et) |
| JP (1) | JP3953424B2 (et) |
| KR (1) | KR100848898B1 (et) |
| CN (1) | CN100400540C (et) |
| AR (1) | AR035685A1 (et) |
| AT (1) | ATE337322T1 (et) |
| AU (1) | AU2002244717B2 (et) |
| BG (1) | BG107984A (et) |
| BR (1) | BR0207433A (et) |
| CA (1) | CA2437505C (et) |
| CY (1) | CY1106448T1 (et) |
| CZ (1) | CZ20032515A3 (et) |
| DE (1) | DE60214138T2 (et) |
| DK (1) | DK1368358T3 (et) |
| EA (1) | EA006747B1 (et) |
| EE (1) | EE200300398A (et) |
| EG (1) | EG23929A (et) |
| ES (1) | ES2271230T3 (et) |
| HK (1) | HK1065537A1 (et) |
| HR (1) | HRP20030647A2 (et) |
| HU (1) | HUP0303270A3 (et) |
| IL (2) | IL157470A0 (et) |
| MX (1) | MXPA03007432A (et) |
| MY (1) | MY137836A (et) |
| NO (1) | NO20033700L (et) |
| NZ (1) | NZ526741A (et) |
| PL (1) | PL208593B1 (et) |
| PT (1) | PT1368358E (et) |
| SI (1) | SI1368358T1 (et) |
| SK (1) | SK11612003A3 (et) |
| TW (1) | TWI257392B (et) |
| WO (1) | WO2002066484A1 (et) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203299D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel compounds |
| CN100349897C (zh) * | 2002-04-02 | 2007-11-21 | 詹森药业有限公司 | 经取代的氨基异唑啉衍生物及其作为抗抑郁药的用途 |
| AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
| CA2494557C (en) * | 2002-08-15 | 2011-10-18 | Janssen Pharmaceutica N.V. | Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| AU2003271567B2 (en) * | 2002-08-21 | 2009-12-24 | Janssen Pharmaceutica N.V. | C6- and C9-substituted chromeno (4, 3-C) isoxazoline derivatives and their use as anti-depressants |
| BRPI0408136A (pt) * | 2003-03-07 | 2006-03-01 | Astellas Pharma Inc | derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda |
| AU2004283196B2 (en) | 2003-09-17 | 2011-08-25 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds |
| EP1944306A1 (en) * | 2003-09-17 | 2008-07-16 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds as serotonin receptor modulators |
| ES2331144T3 (es) * | 2004-11-26 | 2009-12-22 | Janssen Pharmaceutica Nv | Derivados de isoxazolina-indol con actividad antipsicotica y ansiolitica mejorada. |
| NZ579431A (en) | 2007-03-09 | 2012-04-27 | Sanofi Aventis | Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
| EP2164328B8 (en) * | 2007-06-08 | 2013-09-11 | Dart Neuroscience (Cayman) Ltd | Therapeutic pyrazoloquinoline urea derivatives |
| WO2009082268A2 (ru) | 2007-12-21 | 2009-07-02 | Alla Chem, Llc | ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ |
| AR078171A1 (es) | 2009-09-15 | 2011-10-19 | Sanofi Aventis | Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2055011T3 (es) | 1988-09-19 | 1994-08-16 | Akzo Nv | Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano. |
| US5880121A (en) * | 1996-01-05 | 1999-03-09 | Hoechst Marion Roussel Inc. | 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof |
| NZ329954A (en) * | 1996-04-12 | 1999-07-29 | Janssen Pharmaceutica Nv | Isoxazolidine tetracyclic and tricyclic ring system derivatives and medicaments |
| HUP9602763A3 (en) * | 1996-10-09 | 1999-05-28 | Egyt Gyogyszervegyeszeti Gyar | 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same |
| WO2000021959A1 (en) * | 1998-10-09 | 2000-04-20 | Janssen Pharmaceutica N.V. | 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
-
2002
- 2002-02-13 MX MXPA03007432A patent/MXPA03007432A/es active IP Right Grant
- 2002-02-13 CZ CZ20032515A patent/CZ20032515A3/cs unknown
- 2002-02-13 BR BR0207433-8A patent/BR0207433A/pt not_active IP Right Cessation
- 2002-02-13 JP JP2002565998A patent/JP3953424B2/ja not_active Expired - Lifetime
- 2002-02-13 EP EP02712909A patent/EP1368358B1/en not_active Expired - Lifetime
- 2002-02-13 EE EEP200300398A patent/EE200300398A/et unknown
- 2002-02-13 WO PCT/EP2002/001567 patent/WO2002066484A1/en active IP Right Grant
- 2002-02-13 KR KR1020037008328A patent/KR100848898B1/ko not_active IP Right Cessation
- 2002-02-13 PT PT02712909T patent/PT1368358E/pt unknown
- 2002-02-13 CA CA2437505A patent/CA2437505C/en not_active Expired - Lifetime
- 2002-02-13 US US10/468,555 patent/US7169786B2/en not_active Expired - Lifetime
- 2002-02-13 HU HU0303270A patent/HUP0303270A3/hu unknown
- 2002-02-13 AT AT02712909T patent/ATE337322T1/de not_active IP Right Cessation
- 2002-02-13 IL IL15747002A patent/IL157470A0/xx unknown
- 2002-02-13 NZ NZ526741A patent/NZ526741A/en unknown
- 2002-02-13 DE DE60214138T patent/DE60214138T2/de not_active Expired - Lifetime
- 2002-02-13 AU AU2002244717A patent/AU2002244717B2/en not_active Expired
- 2002-02-13 PL PL363264A patent/PL208593B1/pl unknown
- 2002-02-13 ES ES02712909T patent/ES2271230T3/es not_active Expired - Lifetime
- 2002-02-13 CN CNB028052439A patent/CN100400540C/zh not_active Expired - Fee Related
- 2002-02-13 SI SI200230433T patent/SI1368358T1/sl unknown
- 2002-02-13 DK DK02712909T patent/DK1368358T3/da active
- 2002-02-13 EA EA200300915A patent/EA006747B1/ru not_active IP Right Cessation
- 2002-02-13 SK SK1161-2003A patent/SK11612003A3/sk unknown
- 2002-02-19 MY MYPI20020548A patent/MY137836A/en unknown
- 2002-02-19 EG EG20020197A patent/EG23929A/xx active
- 2002-02-20 TW TW091102853A patent/TWI257392B/zh not_active IP Right Cessation
- 2002-02-20 AR ARP020100583A patent/AR035685A1/es unknown
-
2003
- 2003-07-08 BG BG107984A patent/BG107984A/bg unknown
- 2003-08-12 HR HR20030647A patent/HRP20030647A2/hr not_active Application Discontinuation
- 2003-08-19 IL IL157470A patent/IL157470A/en unknown
- 2003-08-20 NO NO20033700A patent/NO20033700L/no not_active Application Discontinuation
-
2004
- 2004-10-25 HK HK04108329.1A patent/HK1065537A1/xx not_active IP Right Cessation
-
2006
- 2006-11-22 CY CY20061101693T patent/CY1106448T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1078266A1 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same | |
| PT1757606E (pt) | Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação | |
| SI1427711T1 (sl) | Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva | |
| EP1367060A4 (en) | GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE | |
| EP1364957A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE | |
| HK1083831A1 (en) | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof | |
| EP1364958A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | |
| HK1068555A1 (en) | New formulations and use thereof | |
| ZA200204020B (en) | Use of anti-CTLA-4-antibodies. | |
| HUP0401335A3 (en) | Herbicidal pyridylpropynyloxyphenyl derivatives, preparation and use thereof | |
| HUP0300268A3 (en) | Herbicidal benzoylpyrazole derivatives, compositions containing the same and their use | |
| DE60208622D1 (de) | Siliciumoxidpulver und dessen Herstellung | |
| HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
| IL156161A0 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors | |
| HK1081954A1 (en) | Novel 1,4-diazabicycloalkane derivatives, their preparation and use | |
| IL155520A0 (en) | Benzoxazinone derivatives, their preparation and use | |
| EG23929A (en) | Isoxazolines derivatives and their use as antidepressants | |
| HUP0401092A3 (en) | 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof | |
| ZA200309513B (en) | Novel heterocyclic derivatives and medicinal use thereof. | |
| IL158056A0 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| MXPA03001826A (es) | Derivados de arilpiperazina. | |
| SI1532141T1 (sl) | 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi | |
| HUP0600238A3 (en) | Benzothiazole- and benzoxazole-4,7-dione derivatives and their use | |
| HK1066022A1 (en) | Use of 1,1,1,3,3-pentafluorobutan | |
| EP1367123A4 (en) | NEUROTONIN AND ITS USE |